immatics biotechnologies GmbH (IMTXW) — Net Asset Momentum
immatics biotechnologies GmbH (IMTXW) recorded a net asset momentum of 155.4% as of December 2024, with net assets of $574.84 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is immatics biotechnologies GmbH's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
immatics biotechnologies GmbH Net Asset Momentum (2018–2024)
This chart tracks immatics biotechnologies GmbH's year-over-year net asset growth across 7 annual reporting periods from 2018 to 2024. The most recent momentum reading is +155.4%, with net assets of $574.84 Million USD as of December 2024. For live market cap and overall valuation, see IMTXW stock market capitalisation.
Annual Net Asset History for immatics biotechnologies GmbH (2018–2024)
The table below shows the complete annual net asset history for immatics biotechnologies GmbH from 2018 to 2024, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check how tangible is immatics biotechnologies GmbH's equity to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $574.84 Million | $696.15 Million | $121.30 Million | ▲ +155.4% |
| 2023 | $225.08 Million | $509.96 Million | $284.88 Million | ▲ +5.6% |
| 2022 | $213.16 Million | $407.82 Million | $194.66 Million | ▲ +785.9% |
| 2021 | $24.06 Million | $174.65 Million | $150.58 Million | ▼ -76.9% |
| 2020 | $104.26 Million | $254.65 Million | $150.39 Million | ▲ +355.3% |
| 2019 | $-40.84 Million | $134.28 Million | $175.11 Million | ▼ -345.3% |
| 2018 | $-9.17 Million | $61.32 Million | $70.49 Million | — |